AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 142 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,684 | -42.5% | 3,869 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $42,907 | -20.8% | 3,869 | +9.6% | 0.00% | -33.3% |
| Q1 2023 | $54,201 | -26.2% | 3,531 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $73,471 | +51.4% | 3,311 | +11.4% | 0.00% | +50.0% |
| Q3 2022 | $48,533 | +12.4% | 2,972 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $43,183 | +5.9% | 2,972 | +34.6% | 0.00% | +100.0% |
| Q1 2022 | $40,782 | -81.7% | 2,208 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $222,701 | -3.5% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $230,758 | -0.3% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $231,508 | +18.6% | 9,369 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $195,156 | +50.6% | 8,948 | +76.2% | 0.00% | +50.0% |
| Q4 2020 | $129,565 | -9.3% | 5,077 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $142,918 | – | 5,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |